title: Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
abstract: Glioblastoma multiforme (GBM) is the most common and lethal form of brain cancer and these tumors are highly resistant to chemo- and radiotherapy. Radioresistance is thought to result from a paucity of molecular oxygen in hypoxic tumor regions, resulting in reduced DNA damage and enhanced cellular defense mechanisms. Efforts to counteract tumor hypoxia during radiotherapy are limited by an attendant increase in the sensitivity of healthy brain tissue to radiation. However, the presence of heightened levels of molecular oxygen during radiotherapy, while conventionally deemed critical for adjuvant oxygen therapy to sensitize hypoxic tumor tissue, might not actually be necessary. We evaluated the concept that pre-treating tumor tissue by transiently elevating tissue oxygenation prior to radiation exposure could increase the efficacy of radiotherapy, even when radiotherapy is administered after the return of tumor tissue oxygen to hypoxic baseline levels. Using nude mice bearing intracranial U87-luciferase xenografts, and in vitro models of tumor hypoxia, the efficacy of oxygen pretreatment for producing radiosensitization was tested. Oxygen-induced radiosensitization of tumor tissue was observed in GBM xenografts, as seen by suppression of tumor growth and increased survival. Additionally, rodent and human glioma cells, and human glioma stem cells, exhibited prolonged enhanced vulnerability to radiation after oxygen pretreatment in vitro, even when radiation was delivered under hypoxic conditions. Over-expression of HIF-1α reduced this radiosensitization, indicating that this effect is mediated, in part, via a change in HIF-1-dependent mechanisms. Importantly, an identical duration of transient hyperoxic exposure does not sensitize normal human astrocytes to radiation in vitro. Taken together, these results indicate that briefly pre-treating tumors with elevated levels of oxygen prior to radiotherapy may represent a means for selectively targeting radiation-resistant hypoxic cancer cells, and could serve as a safe and effective adjuvant to radiation therapy for patients with GBM.
authors.affiliation: Department of Neuroscience, University of Virginia, Charlottesville, VA, United States of America; School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America.
authors.forename: Ryon H
authors.initials: RH
authors.lastname: Clarke
authors.affiliation: School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America.
authors.forename: Shayan
authors.initials: S
authors.lastname: Moosa
authors.affiliation: Department of Neuroscience, University of Virginia, Charlottesville, VA, United States of America; School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America.
authors.forename: Matthew
authors.initials: M
authors.lastname: Anzivino
authors.affiliation: Department of Neuroscience, University of Virginia, Charlottesville, VA, United States of America; School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America.
authors.forename: Yi
authors.initials: Y
authors.lastname: Wang
authors.affiliation: School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America; Division of Neuro-Oncology, Departments of Neurology, Microbiology, and Biochemistry and Molecular Genetics, University of Virginia Health System, Charlottesville, VA, United States of America.
authors.forename: Desiree Hunt
authors.initials: DH
authors.lastname: Floyd
authors.affiliation: School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America; Division of Neuro-Oncology, Departments of Neurology, Microbiology, and Biochemistry and Molecular Genetics, University of Virginia Health System, Charlottesville, VA, United States of America.
authors.forename: Benjamin W
authors.initials: BW
authors.lastname: Purow
authors.affiliation: Department of Neuroscience, University of Virginia, Charlottesville, VA, United States of America; School of Medicine, University of Virginia Health System, Charlottesville, VA, United States of America; Department of Neurological Surgery, University of Virginia, Charlottesville, VA, United States of America.
authors.forename: Kevin S
authors.initials: KS
authors.lastname: Lee
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D015687:Cell Hypoxia / Q000187:drug effects; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D005260:Female; D005909:Glioblastoma / Q000473:pathology; D005910:Glioma / Q000473:pathology* / Q000532:radiotherapy*; D006801:Humans; D000860:Hypoxia / Q000473:pathology; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000473:pathology; D010100:Oxygen / Q000737:chemistry*; D011836:Radiation Tolerance / Q000235:genetics; D011838:Radiation-Sensitizing Agents / Q000737:chemistry*; D011878:Radiotherapy / Q000379:methods
chemical_list: D011838:Radiation-Sensitizing Agents; D010100:Oxygen